These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2417864)

  • 1. Peptides and histamine release from rat peritoneal mast cells.
    Devillier P; Renoux M; Giroud JP; Regoli D
    Eur J Pharmacol; 1985 Oct; 117(1):89-96. PubMed ID: 2417864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cationic peptides on rat ileum muscle contraction and histamine release from rat peritoneal mast cells.
    Wan BY; Peh KH; Yue SC; Assem ES; Pearce FL
    Inflamm Res; 2002 Apr; 51 Suppl 1():S15-6. PubMed ID: 12013390
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
    Bueb JL; Mousli M; Bronner C; Rouot B; Landry Y
    Mol Pharmacol; 1990 Dec; 38(6):816-22. PubMed ID: 1701214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides.
    Devillier P; Drapeau G; Renoux M; Regoli D
    Eur J Pharmacol; 1989 Sep; 168(1):53-60. PubMed ID: 2479572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine release from rat peritoneal mast cells by kinin antagonists.
    Devillier P; Renoux M; Drapeau G; Regoli D
    Eur J Pharmacol; 1988 Apr; 149(1-2):137-40. PubMed ID: 2456220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins.
    Devillier P; Regoli D; Asseraf A; Descours B; Marsac J; Renoux M
    Pharmacology; 1986; 32(6):340-7. PubMed ID: 2425383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pertussis toxin-sensitive G protein is required to induce histamine release from rat peritoneal mast cells by bradykinin.
    Bueb JL; Mousli M; Landry Y; Bronner C
    Agents Actions; 1990 Apr; 30(1-2):98-101. PubMed ID: 1695472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of histamine from mast cells by vasoactive peptides.
    Johnson AR; Erdös EG
    Proc Soc Exp Biol Med; 1973 Apr; 142(4):1252-6. PubMed ID: 4121082
    [No Abstract]   [Full Text] [Related]  

  • 9. [General principles of mast cell activation by cyclic analogs of basic vasoactive peptides].
    Porunkevich EA; Ratkevich MP; Kublis GG; Mutulis FK; Chipens GI
    Biokhimiia; 1990 Jun; 55(6):988-94. PubMed ID: 1698465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect.
    Håkanson R; Leander S; Asano N; Feng DM; Folkers K
    Regul Pept; 1990 Oct; 31(1):75-82. PubMed ID: 1702895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structural features of linear and cyclic analogs of angiotensin, affecting secretion of histamine from rat mast cells].
    Ratkevich MP; Porunkevich EA; Antsans IuE; Chipens GI
    Biokhimiia; 1989 Oct; 54(10):1611-6. PubMed ID: 2481506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides.
    Levi-Schaffer F; Shalit M
    Int Arch Allergy Appl Immunol; 1989; 90(4):352-7. PubMed ID: 2482257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats.
    Ogawa K; Nabe T; Yamamura H; Kohno S
    Eur J Pharmacol; 1999 Jun; 374(2):285-91. PubMed ID: 10422770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin.
    Piotrowski W; Foreman JC
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):364-8. PubMed ID: 2419771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological evaluation of substance P antagonists.
    Folkers K; Håkanson R; Hörig J; Xu JC; Leander S
    Br J Pharmacol; 1984 Oct; 83(2):449-56. PubMed ID: 6207886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.
    Lowman MA; Benyon RC; Church MK
    Br J Pharmacol; 1988 Sep; 95(1):121-30. PubMed ID: 2464382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine release from isolated rat mast cells by neurotensin and other peptides.
    Sydbom A
    Agents Actions; 1982 Apr; 12(1-2):90-3. PubMed ID: 6177223
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of histamine by neuropeptides from the perfused rat hindquarter.
    Skofitsch G; Donnerer J; Petronijevic S; Saria A; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):153-7. PubMed ID: 6191225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.